Interaction between B and CD4 T cells is crucial for their optimal responses in adaptive immunity. Immune responses augmented by their partnership promote chronic
inflammation. Here we report that interaction between B and CD4 T cells augments their atherogenicity to promote
lipid-induced
atherosclerosis. Genetic deletion of the gene encoding
immunoglobulin mu (μ) heavy chain (μMT) in
ApoE-/- mice resulted in global loss of B cells including those in
atherosclerotic plaques, undetectable
immunoglobulins and impaired germinal center formation. Despite unaffected numbers in the circulation and peripheral lymph nodes, CD4 T cells were also reduced in spleens as were activated and memory CD4 T cells. In hyperlipidemic μMT-/-
ApoE-/- mice, B cell deficiency decreased atherosclerotic lesions, accompanied by absence of
immunoglobulins and reduced CD4 T cell accumulation in lesions. Adoptive transfer of B cells deficient in either MHCII or co-stimulatory molecule CD40, molecules required for B and CD4 T cell interaction, into B cell-deficient μMT-/-
ApoE-/- mice failed to increase
atherosclerosis. In contrast, wildtype B cells transferred into μMT-/-
ApoE-/- mice increased
atherosclerosis and increased CD4 T cells in lesions including activated and memory CD4 T cells. Transferred B cells also increased their expression of atherogenic
cytokines IL-1β, TGF-β, MCP-1,
M-CSF, and MIF, with partial restoration of germinal centers and plasma
immunoglobulins. Our study demonstrates that interaction between B and CD4 T cells utilizing MHCII and CD40 is essential to augment their function to increase
atherosclerosis in hyperlipidemic mice. These findings suggest that targeting B cell and CD4 T cell interaction may be a therapeutic strategy to limit
atherosclerosis progression.